Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)
Titel:
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)
Auteur:
Advani, Anjali S. Li, Hongli Michaelis, Laura C. Medeiros, Bruno C. Liedtke, Michaela List, Alan F. O’Dwyer, Kristen Othus, Megan Erba, Harry P. Appelbaum, Frederick R.